APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 27 filers reported holding APTEVO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,634 | -77.4% | 11,013 | 0.0% | 0.00% | – |
| Q2 2023 | $16,079 | -28.3% | 11,013 | 0.0% | 0.00% | – |
| Q1 2023 | $22,412 | -14.6% | 11,013 | -2.7% | 0.00% | – |
| Q4 2022 | $26,246 | -54.0% | 11,313 | -39.9% | 0.00% | – |
| Q3 2022 | $57,000 | -28.8% | 18,814 | -15.5% | 0.00% | – |
| Q2 2022 | $80,000 | -73.3% | 22,272 | -56.4% | 0.00% | – |
| Q1 2022 | $300,000 | -66.0% | 51,096 | -54.4% | 0.00% | – |
| Q4 2021 | $883,000 | +419.4% | 112,155 | +917.0% | 0.00% | – |
| Q3 2021 | $170,000 | -9.1% | 11,028 | +31.9% | 0.00% | – |
| Q2 2021 | $187,000 | +92.8% | 8,364 | +163.4% | 0.00% | – |
| Q1 2021 | $97,000 | -18.5% | 3,175 | -2.3% | 0.00% | – |
| Q4 2020 | $119,000 | +3866.7% | 3,251 | +691.0% | 0.00% | – |
| Q3 2020 | $3,000 | -95.8% | 411 | -95.2% | 0.00% | – |
| Q2 2020 | $71,000 | +7000.0% | 8,558 | +2146.2% | 0.00% | – |
| Q1 2020 | $1,000 | – | 381 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,760,000 | $64,504,000 | 9.85% |
| Stonepine Capital Management, LLC | 18,280 | $670,000 | 0.51% |
| Ghost Tree Capital, LLC | 50,000 | $1,833,000 | 0.41% |
| Anson Funds Management LP | 45,462 | $1,666,000 | 0.34% |
| RTW INVESTMENTS, LP | 288,236 | $10,564,000 | 0.18% |
| Dynamic Technology Lab Private Ltd | 13,202 | $484,000 | 0.08% |
| Alyeska Investment Group, L.P. | 49,601 | $1,818,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11,493 | $421,000 | 0.02% |
| PURA VIDA INVESTMENTS, LLC | 8,203 | $301,000 | 0.01% |
| Renaissance Technologies | 254,423 | $9,325,000 | 0.01% |